(1)
Byrd, K.; Truong, P. Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. kjm 2014, 7 (4), 167-170. https://doi.org/10.17161/kjm.v7i4.11507.